Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 22:22:00 UTC |
---|
Update Date | 2021-09-26 23:17:17 UTC |
---|
HMDB ID | HMDB0259625 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- |
---|
Description | N-(5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-2-{[2-(pyridin-4-yl)ethyl]imino}-1,2,3,4-tetrahydropyrimidin-4-ylidene)propan-1-amine belongs to the class of organic compounds known as aminopyrimidines and derivatives. These are organic compounds containing an amino group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Based on a literature review very few articles have been published on N-(5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-2-{[2-(pyridin-4-yl)ethyl]imino}-1,2,3,4-tetrahydropyrimidin-4-ylidene)propan-1-amine. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2,4-pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-n4-propyl-n2-(2-(4-pyridinyl)ethyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 InChI=1S/C21H29N9O/c1-2-6-24-19-17(20-29-28-18(31-20)15-30-12-10-23-11-13-30)14-26-21(27-19)25-9-5-16-3-7-22-8-4-16/h3-4,7-8,14,23H,2,5-6,9-13,15H2,1H3,(H2,24,25,26,27) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H29N9O |
---|
Average Molecular Weight | 423.525 |
---|
Monoisotopic Molecular Weight | 423.24950659 |
---|
IUPAC Name | 5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-N4-propyl-N2-[2-(pyridin-4-yl)ethyl]pyrimidine-2,4-diamine |
---|
Traditional Name | 5-[5-(piperazin-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-N4-propyl-N2-[2-(pyridin-4-yl)ethyl]pyrimidine-2,4-diamine |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 |
---|
InChI Identifier | InChI=1S/C21H29N9O/c1-2-6-24-19-17(20-29-28-18(31-20)15-30-12-10-23-11-13-30)14-26-21(27-19)25-9-5-16-3-7-22-8-4-16/h3-4,7-8,14,23H,2,5-6,9-13,15H2,1H3,(H2,24,25,26,27) |
---|
InChI Key | AOGSXPPPFJBSRA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminopyrimidines and derivatives. These are organic compounds containing an amino group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrimidines and pyrimidine derivatives |
---|
Direct Parent | Aminopyrimidines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Aminopyrimidine
- Aralkylamine
- N-alkylpiperazine
- 1,4-diazinane
- Imidolactam
- Piperazine
- Pyridine
- 1,3,4-oxadiazole
- Azole
- Heteroaromatic compound
- Oxadiazole
- Tertiary aliphatic amine
- Tertiary amine
- Secondary aliphatic amine
- Oxacycle
- Azacycle
- Secondary amine
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 193.736 | 30932474 | DeepCCS | [M-H]- | 191.378 | 30932474 | DeepCCS | [M-2H]- | 225.576 | 30932474 | DeepCCS | [M+Na]+ | 200.804 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 4198.1 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3679.0 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3983.9 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3682.8 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3725.8 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 5488.9 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3685.0 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3733.6 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 5449.2 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3815.7 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3798.9 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 5544.7 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3625.8 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3498.0 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 5162.3 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3746.8 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3723.1 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 5299.1 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3765.0 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3726.7 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 5247.2 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3744.9 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3519.4 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 4963.6 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3845.6 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3916.9 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 5535.2 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3853.2 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3922.6 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 5474.3 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 4025.6 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 3988.4 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 5662.5 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3943.8 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3910.4 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 5180.8 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4085.0 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4076.7 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 5412.1 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 4121.3 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 4077.1 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 5336.9 | Standard polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4240.9 | Semi standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4112.4 | Standard non polar | 33892256 | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 5071.0 | Standard polar | 33892256 |
|
---|